Griffin felt like ... look at obesity as: it’s one’s disease. It almost certainly is not one disease.” Griffin, a 38-year-old information technology worker from New Mexico, started on ...

A fast-growing body of research signals potential health benefits of GLP-1s, the class of diabetes and weight-loss drugs known by names like Ozempic, beyond what they were initially approved to treat.

short for glucagon-like peptide 1 and sold under brand names like Ozempic, Wegovy and Mounjaro to treat diabetes and obesity. Sarah Laing is a Toronto-based freelance contributor for The Star ...